ReviewCardiovascular & hematological disorders drug targets2026
Tattoo Ink Exposure and Its Potential Link with Lymphoma and Skin Cancer: A Narrative Review of New Evidence.
Review in Cardiovascular & hematological disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTattooing, which is becoming more and more widespread in the world, makes it necessary to care about the long-term health consequences of tattoo ink exposure and its potential association with skin and lymphatic carcinogenesis.
methodsA narrative review was performed by searching peer-reviewed articles in PubMed written up to the year 2025. The search words were "tattoo ink," "skin cancer," "lymphoma," "tattoo-associated malignancy," "carcinogenic pigments," "polycyclic aromatic hydrocarbons (PAHs)," "heavy metals in tattoo inks," and "nanoparticle migration." Papers were chosen for their relevance to the composition, migration of pigments, toxicological mechanisms, and documented associations with cancer.
resultsTattoo inks may contain substances such as PAHs, azo dyes, titanium dioxide, and heavy metals. It is possible for these particles to deteriorate with UV illumination and migrate to lymph nodes, causing chronic inflammation and oxidative stress. Imaging demonstrates the nanoparticle localisation within lymphatic organs, whereas toxicological studies associate genotoxicity and immune damage with components of the pigment. There are a few clinical case reports and a few population-based studies indicating a potential relationship with lymphoma and skin malignancies. DISCUSSION: While causality has not been proven, supportive evidence across toxicologic and clinical spheres suggests a biologically plausible risk for cancer. Limitations of this study are heterogeneity in design and ink, as well as the absence of long-term cohort data. Regulatory and labelling requirements are also not well synchronized across the world.
conclusionAt the chemical and biological level, exposure to tattoo ink can increase the risk of carcinogenesis. Additional research and more stringent regulations are needed to establish and mitigate potential long-term health risks.
Indexed as
Identifiers
41588965What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.